HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1429671Generated: October 31, 2026
Ethanol → (11aS)-2-(4-Aminophenyl)-8-[[5-[[(11aS)-5,11a-dihydro-7-methoxy-2-(4-methoxyphenyl)-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]pentyl]oxy]-1,11a-dihydro-7-methoxy-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one
https://huagongshe.com/reaction/1429671
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethanol | HCID 702 | — |
| Reactant | Lithium borohydride | HCID 4148881 | — |
| Reactant | HCID 86656480 | HCID 86656480 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | (11aS)-2-(4-Aminophenyl)-8-[[5-[[(11aS)-5,11a-dihydro-7-methoxy-2-(4-methoxyphenyl)-5-oxo-1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]pentyl]oxy]-1,11a-dihydro-7-methoxy-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one | HCID 45376561 | 52% |
Reaction Steps
Fresh LiBH4 (66 mg, 3.04 mmol) was added to a stirred solution of the SEM-dilactam 12 (428 mg, 0.42 mmol) in THF (3 mL) and EtOH (3 mL) at 0° C. (ice bath). The ice bath was removed and the reaction mixture was allowed to reach room temperature (vigorous effervescence). After 2 hours LC/MS analysis indicated the complete consumption of starting material. The reaction mixture was poured onto ice (50 mL) and allowed to warm to room temperature with stirring. The aqueous mixture was extracted with DCM (3×50 mL) and the combined organic layers washed with H2O (50 mL), brine (50 mL), dried (MgSO4) and concentrated in vacuo. The resulting residue was treated with DCM (2 mL), EtOH (5 mL), H2O (2.5 mL) and silica gel (3.7 g). The viscous mixture was allowed to stir at room temperature for 3 days. The mixture was filtered through a sinter funnel and the silica residue washed with 90% CHCl3: 10% MeOH (˜250 mL) until UV activity faded completely from the eluent. The organic phase was dried (MgSO4) filtered and evaporated in vacuo to provide the crude material. The crude product was purified by flash chromatography (99.5% CHCl3: 0.5% MeOH to 97.5% CHCl3: 2.5% MeOH in 0.5% increments)) to provide the pure C2/C2′ aryl PBD dimer 13 (59 mg, 52%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08940733B2 |
|---|
| Source dataset | uspto-grants-2015_01 |
|---|
| ORD ID | ord-021f9527911a476abc3a41045e84c7e2 |
|---|
| Source note | uspto-grants-2015_01 |
|---|